Retatrutide is a triple-agonist (GLP-1, GIP, glucagon) while Mounjaro is a dual-agonist (GLP-1, GIP)
This separation provides theoretical safety, though the combination remains unstudied in formal clinical trials
For those who have previously struggled with the high price of brand-name medications or the barriers of insurance approvals, Sesame's flat-rate structure and monthly semaglutide subscription model are often cited as major advantages
Currently, there are no clinical studies that directly compare the average weight reduction of people taking Mounjaro and retatrutide
Its on hunger centers in the brain, where it reduces cravings by silencing the signals that cause them, making it easier to commit to smaller meals
Slowed gastric emptying on GLP-1 medications can reduce how well oral contraceptives are absorbed